测试条市场规模、份额和成长分析（按产品类型、功能、应用、最终用户和地区）- 产业预测，2025-2032 年

2023 年全球试纸市场规模价值 55 亿美元，预计将从 2024 年的 60.2 亿美元成长到 2032 年的 124.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.5%。

COVID-19 疫情大大重塑了全球试纸市场。儘管由于对感染传播的担忧，试纸的初始需求大幅下降，但对 COVID-19 诊断的研究和开发却激增。同时，预计全球糖尿病和尿道感染（UTI）盛行率上升将在整个预测期内推动市场成长。世界卫生组织（WHO）预测，到2031年，糖尿病将成为第七大死因，尤其影响中低收入国家。人们对血糖值测试纸的认识和接受度不断提高，使得患者能够在家中进行自我测试（通常每天两到三次），正在推动市场扩张。这些趋势凸显了不断发展的医疗保健环境中对可访问、高效的家庭检测解决方案的迫切需求。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

试纸市场规模（依产品类型及复合年增长率） (2025-2032)

• 市场概况
• 血液试纸
• 尿液检查
• 糖尿病条
• 萤光素
• 其他的

试纸市场规模（按功能和复合年增长率） (2025-2032)

• 市场概况
• 视觉试纸
• 自动试纸

试纸市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 糖尿病
• 感染疾病
• 心臟标记检测
• 妊娠和不孕症检测
• 其他的

测试条市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院和诊所
• 居家护理
• 诊断实验室
• 其他的

试纸市场规模（依地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Abbott Laboratories（USA）
• Acon Laboratories（USA）
• Arkray（Japan）
• B. Braun（Germany）
• Lifescan（USA）
• Roche（Switzerland）
• Siemens Healthineers（Germany）
• Tiadoc Technology（China）
• Teco Diagnostics（USA）
• Becton, Dickinson and Company（USA）
• Johnson & Johnson（USA）
• Bio-Rad Laboratories（USA）
• BioMerieux（France）
• Chembio Diagnostic Systems（USA）
• Nipro Corporation（Japan）
• PTS Diagnostics（USA）
• Quidel Corporation（USA）
• Trinity Biotech（Ireland）
• Wondfo Biotech（China）

结论和建议

Global Test Strip Market size was valued at USD 5.5 billion in 2023 and is poised to grow from USD 6.02 billion in 2024 to USD 12.45 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The COVID-19 pandemic has significantly reshaped the global test strip market. Initially, the demand for test strips plummeted due to infection transmission concerns, but research and development in COVID-19 diagnostics have soared. Concurrently, the rising global prevalence of diabetes and urinary tract infections (UTIs) is expected to propel market growth throughout the forecast period. The World Health Organization projects diabetes will rank as the seventh-leading cause of death by 2031, particularly affecting low- and middle-income countries. Increasing awareness and acceptance of blood glucose test strips, which enable patients to self-test at home-typically 2-3 times daily-are driving their market expansion. This growing trend underscores the critical need for accessible and efficient at-home testing solutions in an evolving healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Test Strip market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Test Strip Market Segmental Analysis

Global Test Strip Market is segmented by Product Type, Function, Application, End User and region. Based on Product Type, the market is segmented into Blood Test Strips, Urine Test Strips, Diabetic Strips, Fluorescein and Others. Based on Function, the market is segmented into Visual Test Strips and Automated Test Strips. Based on Application, the market is segmented into Diabetes, Infectious Disease, Cardiac Marker Testing, Pregnancy & Fertility Testing and Others. Based on End User, the market is segmented into Hospitals & Clinics, Homecare, Diagnostic Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Test Strip Market

The global Test Strip market is significantly driven by the rising prevalence of diabetes worldwide, which is anticipated to fuel market expansion. As the cost of blood glucose test strips (BGTS) continues to garner attention, the traditional categorization of insulin users into a single homogenous group has led to regulations that limit consumption, such as the 8.2 strips per day allowed in provincial prescription insurance systems. Furthermore, the increasing number of diabetes patients will likely enhance market size, share, and revenue. In response to this growing demand, many companies are now providing home-care treatment options along with clear guidelines for caregivers, facilitating better management of diabetes.

Restraints in the Global Test Strip Market

The global test strip market faces significant restraints primarily due to inadequate reimbursement policies that hinder its growth potential. Several insurers have introduced quantity limitations on reimbursements, restricting the annual provision of blood glucose test strips (BGTS) to 400 for patients on hypoglycaemic medications and 200 for others. Furthermore, many insurers do not offer reimbursement for related medications, exacerbating the issue. The high cost of test strips also poses a challenge, making them unaffordable for low-income individuals. These factors collectively limit access and affordability, creating substantial barriers to market expansion and impacting patient care in managing diabetes effectively.

Market Trends of the Global Test Strip Market

The Global Test Strip market is witnessing significant growth, primarily driven by the rising prevalence of diabetes worldwide. As the number of diabetes cases continues to increase, there is an escalating demand for efficient blood glucose monitoring solutions. Test strips, integral to glucose meters, enable diabetic patients to manage their blood sugar levels effectively and conveniently. This trend is expected to dominate the market in the forecast period, with advancements in technology and increased awareness about diabetes management further propelling the adoption of test strips. As a result, stakeholders in the healthcare sector are focusing on innovations to enhance product availability and accuracy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Test Strip Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Blood Test Strips
• Urine Test Strips
• Diabetic Strips
• Fluorescein
• Others

Global Test Strip Market Size by Function & CAGR (2025-2032)

• Market Overview
• Visual Test Strips
• Automated Test Strips

Global Test Strip Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diabetes
• Infectious Disease
• Cardiac Marker Testing
• Pregnancy & Fertility Testing
• Others

Global Test Strip Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Homecare
• Diagnostic Labs
• Others

Global Test Strip Market Size & CAGR (2025-2032)

• North America (Product Type, Function, Application, End User)
  • US
  • Canada
• Europe (Product Type, Function, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Function, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Function, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Function, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acon Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifescan (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tiadoc Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teco Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chembio Diagnostic Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTS Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wondfo Biotech (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations